Alexandre Escande

2.3k total citations
97 papers, 1.6k citations indexed

About

Alexandre Escande is a scholar working on Surgery, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Alexandre Escande has authored 97 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 31 papers in Obstetrics and Gynecology and 26 papers in Oncology. Recurrent topics in Alexandre Escande's work include Endometrial and Cervical Cancer Treatments (31 papers), Management of metastatic bone disease (17 papers) and Ovarian cancer diagnosis and treatment (13 papers). Alexandre Escande is often cited by papers focused on Endometrial and Cervical Cancer Treatments (31 papers), Management of metastatic bone disease (17 papers) and Ovarian cancer diagnosis and treatment (13 papers). Alexandre Escande collaborates with scholars based in France, United States and Philippines. Alexandre Escande's co-authors include Cyrus Chargari, Éric Deutsch, Christine Haie-Méder, Antoine Schernberg, Sébastien Gouy, Philippe Morice, Éric Lartigau, Isabelle Dumas, R. Mazeron and Enrica Bentivegna and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Alexandre Escande

85 papers receiving 1.6k citations

Peers

Countries citing papers authored by Alexandre Escande

Since Specialization

Citations

This map shows the geographic impact of Alexandre Escande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Escande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Escande more than expected).

Fields of papers citing papers by Alexandre Escande

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Escande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Escande. The network helps show where Alexandre Escande may publish in the future.

Co-authorship network of co-authors of Alexandre Escande

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Escande. A scholar is included among the top collaborators of Alexandre Escande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Escande. Alexandre Escande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art 2025 ·Cancer and Metastasis Reviews ·(unknown), Jean Faivre, (unknown), Alexandre Escande, S. Thureau	0
2	Role of radiotherapy in the management of rare gynaecological cancers 2023 ·Cancer/Radiothérapie ·(unknown), Sophie Espenel, Patrick Tas, Cyrus Chargari, Alexandre Escande	1
3	Enjeux éthiques de l’information en oncologie radiothérapie : penser le risque et construire l’alliance thérapeutique 2023 ·Cancer/Radiothérapie ·(unknown), (unknown), David Osman, (unknown), (unknown), (unknown), R. de Crevoisier, C. Dejean, Alexandre Escande, (unknown), F. Lorchel, S. Thureau, J. L. Lagrange, C. Durdux, F. Huguet	0
4	Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices 2023 ·Cancer/Radiothérapie ·Claire Petit, Alexandre Escande, (unknown), (unknown), Youlia Kirova, Agnès Tallet	5
5	Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne’s Thread in Early Cervical Cancer Treatment? 2023 ·Cancers ·(unknown), (unknown), Carlos Martínez-Gómez, Emilie Bogart, Marie‐Cécile Le Deley, Éric Leblanc, Delphine Hudry, Alexandre Escande, (unknown), (unknown), S. Taïeb, (unknown), Fabrice Narducci	2
6	Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors 2023 ·Cancers ·Clémence Fournier, (unknown), Éric Leblanc, Marie‐Cécile Le Deley, (unknown), Dominique Pasquier, Alexandre Escande, S. Taïeb, L. Ceugnart, Loïc Lebellec	2
7	Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study 2021 ·British Journal of Radiology ·(unknown), (unknown), Ellen Blanc, Anne Ducassou, A. Huchet, C. Vigneron, Alexandre Escande, S. Chapet, Julie Leseur, V. Bernier, C. Carrié, (unknown), L. Claude	8
8	Enjeux éthiques de la pratique des soins à visée palliative en oncologie radiothérapique 2021 ·Cancer/Radiothérapie ·(unknown), (unknown), F. Huguet, R. de Crevoisier, C. Dejean, Alexandre Escande, (unknown), (unknown), Patrick Le Tallec, I. Lecouillard, F. Lorchel, S. Thureau, J. L. Lagrange	2
9	Radiothérapie du carcinome épidermoïde du larynx de stade précoce, étage glottique : intérêt de l’hypofractionnement ? 2021 ·Cancer/Radiothérapie ·(unknown), (unknown), (unknown), X. Mirabel, F. Crop, T. Lacornerie, Dominique Pasquier, Alexandre Escande, X. Liem	1
10	La radiothérapie stéréotaxique peut-elle remplacer la curiethérapie pour les cancers du col utérin localement évolués ? Positionnement de la Société française de radiothérapie oncologique 2020 ·Cancer/Radiothérapie ·Cyrus Chargari, Sophie Renard, Sophie Espenel, Alexandre Escande, (unknown), Anne Ducassou, D. Peiffert, (unknown)	7
11	Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol 2020 ·BMJ Open ·Jennifer Le Guévelou, (unknown), Esma Saâda-Bouzid, Julien Viotti, (unknown), (unknown), Nicolas Penel, Marie Pierre Sunyach, Laurence Moureau-Zabotto, M. Benchalal, (unknown), Anne Ducassou, C. Le Péchoux, (unknown), Céline Bazille, Dominique Vaur, Alexandre Escande, (unknown), (unknown), (unknown)	12
12	Curiethérapie en France en 2020 : synthèse et perspectives du Groupe curiethérapie de la Société française de radiothérapie oncologique 2020 ·Cancer/Radiothérapie ·Jean‐Michel Hannoun‐Lévi, (unknown), Pierre Blanchard, Cyrus Chargari, Alexandre Escande, N. Pierrat, P. Pommier, D. Peiffert	5
13	Intracavitary Preoperative Brachytherapy Followed By Whertheim-Type Hysterectomy in Localized Cervical Cancer: Clinical Data and Toxicity Results from a Single Institution Experience 2019 ·International Journal of Radiation OncologyBiologyPhysics ·B. Bataille, (unknown), Alexandre Escande, (unknown), (unknown), Fabrice Narducci, Éric Leblanc, Delphine Hudry, (unknown), Anne Lesoin, (unknown), S. Taïeb, (unknown), Éric Lartigau, X. Mirabel, (unknown)	2
14	A Chatbot Versus Physicians to Provide Information for Patients With Breast Cancer: Blind, Randomized Controlled Noninferiority Trial 2019 ·Journal of Medical Internet Research ·Jean‐Emmanuel Bibault, Benjamin Chaix, Arthur Guillemassé, (unknown), Alexandre Escande, (unknown), (unknown), Guillaume Delamon, (unknown), Benoît Brouard	120
15	Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC 2018 ·Cancer Medicine ·Paul Lesueur, Alexandre Escande, Juliette Thariat, (unknown), I. Monnet, Alexis B. Cortot, D. Lerouge, S. Danhier, Pascal Dô, Catherine Dubos‐Arvis, C. Chouaïd, Radj Gervais	36
16	La radiothérapie externe guidée par l’imagerie dans le cancer de la prostate ; comment, quand et pourquoi ? 2018 ·Cancer/Radiothérapie ·Alexandre Escande, S. Supiot	3
17	Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma 2017 ·Brachytherapy ·(unknown), Alexandre Escande, Stéphane Temam, Isabelle Dumas, Émilie Routier, (unknown), Pierre Blanchard, François Janot, Christine Mateus, Yungan Tao, Caroline Robert, Éric Deutsch, Christine Haie‐Méder, Cyrus Chargari	12
18	Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients) 2016 ·Radiation Oncology ·(unknown), Alexandre Escande, (unknown), Laurent Mortier, X. Mirabel, Bernard Coche‐Dequeant, Éric Lartigau	12
19	Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters 2016 ·Brachytherapy ·Cyrus Chargari, R. Mazeron, Alexandre Escande, Pierre Maroun, Isabelle Dumas, F. Martinetti, (unknown), Éric Deutsch, Philippe Morice, Christine Haie-Méder	12
20	Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting. 2001 ·PubMed ·Thierry Petit, Christian Borel, (unknown), J F Rodier, Alexandre Escande, (unknown), P Haegèle	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact